Amyloid Beta Peptide (Aβ1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release is a research paper published in Journal of Clinical Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: GM136430 and GM103801
National Institutes of Health
Grant: 5R35GM136430-05
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research
National Institutes of Health
Grant: 5R01GM103801-22
Novel nAChR-Targeted Peptides
NIGMS NIH HHS
Grant: R01 GM103801
NIGMS NIH HHS
Grant: R35 GM136430
Fields of Study
Keywords
Sustainable Development Goals
Amyloid beta peptide (aβ1-42) reverses the cholinergic control of monocytic il-1β release